Jason Slakter, MD and Hanna Coleman, MD of Voiant Clinical discuss how the unique interoperability of Voxeleron’s Orion platform helps drive ophthalmic clinical trial success. Want to learn more about Orion? Request a demo today or check out voxeleron.com/orion.
Optical Coherence Tomography (OCT) angiography opens another exciting chapter in ophthalmic imaging. Based on motion contrast, and in the presence of motion-less structure, OCT angiography (OCT-A) resolves signal due to moving blood flow. It thereby offers a compelling alternative to…
Neuronal loss of ganglion cells in the retina is an established hallmark of a number of diseases. As such, a number of clinical trials use the ganglion cell layer (GCL) thickness - or a complex thereof - as measured with…
The eye as a window to the central nervous system Optical coherence tomography (OCT) is a non-invasive, non-contact structural imaging modality (Huang D, 1991), that has unique utility in a number of life science applications. In ophthalmology it is used…
Optical Coherence Tomography (OCT) has dramatically changed diagnostics in ophthalmology. The first publication of cross-sectional images of the human retina occurred in [Huang 1991], and its commercial introduction soon followed in 1996. Such cross-sectional images of the retina allow clinicians…